iCRT-5

CAS No. 18623-44-4

iCRT-5( iCRT5 )

Catalog No. M12878 CAS No. 18623-44-4

iCRT-5 is a selective, cell-permeable β-catenin responsive transcription (CRT) inhibitor with IC50 of 18 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 336 Get Quote
50MG 1386 Get Quote
100MG 2097 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    iCRT-5
  • Note
    Research use only, not for human use.
  • Brief Description
    iCRT-5 is a selective, cell-permeable β-catenin responsive transcription (CRT) inhibitor with IC50 of 18 nM.
  • Description
    iCRT-5 is a selective, cell-permeable β-catenin responsive transcription (CRT) inhibitor with IC50 of 18 nM; specifically modulates the nuclear transcriptional activity of β-catenin while not affecting its cytoskeletal function in stabilizing adherens junctions at the cell membrane; blocks Wnt/β-catenin-induced target genes and phenotypes in various mammalian and cancer cell lines.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    iCRT5
  • Pathway
    Wnt/Notch/Hedgehog
  • Target
    Beta-catenin
  • Recptor
    Beta-catenin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    18623-44-4
  • Formula Weight
    367.44
  • Molecular Formula
    C16H17NO5S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 36 mg/mL (97.98 mM)
  • SMILES
    O=C(O)CCCN(C/1=O)C(SC1=C/C2=CC=C(OC)C(OC)=C2)=S
  • Chemical Name
    (Z)-4-(5-(3,4-Dimethoxybenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)butanoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Gonsalves FC, et al. Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):5954-63. 2. Anastas JN, et al. Nat Rev Cancer. 2013 Jan;13(1):11-26.
molnova catalog
related products
  • PKF118-310

    A novel small molecule inhibitor of Wnt/beta-catenin signaling that selectively disrupts β-catenin/Tcf4 interaction and inhibits its transcriptional activity.

  • KYA-1797K

    A derivative of KY1220 with improved inhibitory activity for Wnt/β-catenin signaling.

  • LF3

    A small-molecule antagonist of the β-catenin/TCF4 interaction with IC50 of 1.65 and 1.82 uM in AlphaScreen and ELISA assay, respectively.